Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Kura Oncology (KURA) stocks in Canada
Learn how to easily invest in Kura Oncology stocks.
Kura Oncology is a biotechnology business based in the US. Kura Oncology stocks (KURA.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $19.68 – a decrease of 13.64% over the previous week. Kura Oncology employs 116 staff and has a market cap (total outstanding stock value) of $907.8 million.
How to buy shares in Kura Oncology
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – KURA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Kura Oncology?
- Has coronavirus impacted Kura Oncology shares?
- Kura Oncology shares summary
- Compare share dealing platforms
- Is Kura Oncology stock a buy or sell?
- Kura Oncology performance over time
- Kura Oncology's financials
- How volatile are Kura Oncology shares?
- Does Kura Oncology pay a dividend?
- Other common questions
Kura Oncology stock price (NASDAQ:KURA)Use our graph to track the performance of KURA stocks over time.
Kura Oncology shares at a glance
|Latest market close||$11.78|
|52-week range||$12.02 - $36.27|
|50-day moving average||$14.84|
|200-day moving average||$19.56|
|Wall St. target price||$37.57|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.92|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Kura Oncology stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Kura Oncology price performance over time
|1 week (2022-01-13)||N/A|
|1 month (2021-12-20)||N/A|
|3 months (2021-10-22)||-32.92%|
|6 months (2021-07-23)||-37.34%|
|1 year (2021-01-22)||-65.74%|
|2 years (2020-01-24)||-0.17%|
|3 years (2019-01-24)||15.62|
|5 years (2017-01-24)||86.98%|
Kura Oncology financials
|Gross profit TTM||$0|
|Return on assets TTM||-17.29%|
|Return on equity TTM||-29.49%|
|Market capitalisation||$907.8 million|
TTM: trailing 12 months
Kura Oncology share dividends
We're not expecting Kura Oncology to pay a dividend over the next 12 months.
Kura Oncology share price volatility
Over the last 12 months, Kura Oncology's shares have ranged in value from as little as $12.02 up to $36.27. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Kura Oncology's is 1.5474. This would suggest that Kura Oncology's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Kura Oncology overview
Kura Oncology, Inc. , a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. Its pipeline consists of small molecule product candidates that target cancer. The company's lead product candidates are tipifarnib, an orally bioavailable inhibitor of farnesyl transferase that is in Phase II clinical trials for the treatment of solid tumors and hematologic indications; and KO-539, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia. Kura Oncology, Inc. has a clinical collaboration with Novartis to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression or PIK3CA mutation and/or amplification. The company was founded in 2014 and is headquartered in San Diego, California.
Stocks similar to Kura Oncology
Kura Oncology in the news
Earnings playbook: A complete guide to this week's reports, including the first of tech
Markets are expected to remain on edge as the Fed meets in the week ahead
FDA Lifts Partial Hold On Kura Oncology's Early-Stage Leukemia Trial
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.Read more…
Review the benefits and risks of investing in these tech-focused ETFs.Read more…
We've rounded up stats on some of the most popular electric stocks, along with information on how they compare and how to invest. Read more…
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.